Allogenic Umbilical Cord Mesenchymal Stem Cell (University of Indonesia)

N/A

Report date: 2023/07/10 20:00:27

Base Information

Drug NameAllogenic Umbilical Cord Mesenchymal Stem Cell (University of Indonesia)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsDiabetes Mellitus, Type 2ST Elevation Myocardial InfarctionOsteoarthritis, Knee

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndonesia

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesIndonesia University

China Registration ClassN/A

Develop Information

Active CompaniesIndonesia University

Inactive CompaniesN/A

Active IndicationsST Elevation Myocardial Infarction

Inactive IndicationsDiabetes Mellitus, Type 2Osteoarthritis, Knee

Other Information

ATC CodeN/A